mirtazapine
Ligand Summary
A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
UNII: A051Q2099Q
PubChem: 4205
Guide to Pharmacology: 7241
ChEMBL: CHEMBL654
DrugCentral: 1816
LyCHI: XK16RJ438FW2
Target Activities
21 Activities
Items per page:
1 – 10 of 21
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||